vs
Side-by-side financial comparison of Cricut, Inc. (CRCT) and AMICUS THERAPEUTICS, INC. (FOLD). Click either name above to swap in a different company.
Cricut, Inc. is the larger business by last-quarter revenue ($203.6M vs $185.2M, roughly 1.1× AMICUS THERAPEUTICS, INC.). Cricut, Inc. runs the higher net margin — 3.8% vs 0.9%, a 2.9% gap on every dollar of revenue. On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs -2.7%). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs 10.3%).
Cricut, Inc. is an American brand of cutting plotters, or computer-controlled cutting machines, designed for home crafters. The machines are used for cutting paper, felt, vinyl, fabric and other materials such as leather, matboard, and wood.
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
CRCT vs FOLD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $203.6M | $185.2M |
| Net Profit | $7.8M | $1.7M |
| Gross Margin | 47.4% | 85.7% |
| Operating Margin | 6.8% | 8.6% |
| Net Margin | 3.8% | 0.9% |
| Revenue YoY | -2.7% | 23.7% |
| Net Profit YoY | -34.7% | -88.5% |
| EPS (diluted) | $0.03 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $203.6M | $185.2M | ||
| Q3 25 | $170.4M | $169.1M | ||
| Q2 25 | $172.1M | $154.7M | ||
| Q1 25 | $162.6M | $125.2M | ||
| Q4 24 | $209.3M | $149.7M | ||
| Q3 24 | $167.9M | $141.5M | ||
| Q2 24 | $167.9M | $126.7M | ||
| Q1 24 | $167.4M | $110.4M |
| Q4 25 | $7.8M | $1.7M | ||
| Q3 25 | $20.5M | $17.3M | ||
| Q2 25 | $24.5M | $-24.4M | ||
| Q1 25 | $23.9M | $-21.7M | ||
| Q4 24 | $11.9M | $14.7M | ||
| Q3 24 | $11.5M | $-6.7M | ||
| Q2 24 | $19.8M | $-15.7M | ||
| Q1 24 | $19.6M | $-48.4M |
| Q4 25 | 47.4% | 85.7% | ||
| Q3 25 | 55.2% | 88.5% | ||
| Q2 25 | 59.0% | 90.2% | ||
| Q1 25 | 60.5% | 90.7% | ||
| Q4 24 | 44.9% | 90.1% | ||
| Q3 24 | 46.1% | 90.6% | ||
| Q2 24 | 53.5% | 91.1% | ||
| Q1 24 | 54.7% | 87.7% |
| Q4 25 | 6.8% | 8.6% | ||
| Q3 25 | 13.3% | 20.3% | ||
| Q2 25 | 17.5% | -6.1% | ||
| Q1 25 | 18.0% | -6.3% | ||
| Q4 24 | 6.6% | 10.7% | ||
| Q3 24 | 6.3% | 15.3% | ||
| Q2 24 | 15.7% | 11.8% | ||
| Q1 24 | 15.1% | -25.1% |
| Q4 25 | 3.8% | 0.9% | ||
| Q3 25 | 12.0% | 10.2% | ||
| Q2 25 | 14.2% | -15.8% | ||
| Q1 25 | 14.7% | -17.3% | ||
| Q4 24 | 5.7% | 9.8% | ||
| Q3 24 | 6.8% | -4.8% | ||
| Q2 24 | 11.8% | -12.4% | ||
| Q1 24 | 11.7% | -43.9% |
| Q4 25 | $0.03 | $0.00 | ||
| Q3 25 | $0.10 | $0.06 | ||
| Q2 25 | $0.11 | $-0.08 | ||
| Q1 25 | $0.11 | $-0.07 | ||
| Q4 24 | $0.06 | $0.05 | ||
| Q3 24 | $0.05 | $-0.02 | ||
| Q2 24 | $0.09 | $-0.05 | ||
| Q1 24 | $0.09 | $-0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $275.6M | $293.5M |
| Total DebtLower is stronger | — | $392.7M |
| Stockholders' EquityBook value | $343.6M | $274.2M |
| Total Assets | $580.8M | $949.9M |
| Debt / EquityLower = less leverage | — | 1.43× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $275.6M | $293.5M | ||
| Q3 25 | $207.1M | $263.8M | ||
| Q2 25 | $376.9M | $231.0M | ||
| Q1 25 | $356.7M | $250.6M | ||
| Q4 24 | $336.9M | $249.9M | ||
| Q3 24 | $246.9M | $249.8M | ||
| Q2 24 | $299.5M | $260.1M | ||
| Q1 24 | $281.7M | $239.6M |
| Q4 25 | — | $392.7M | ||
| Q3 25 | — | $392.0M | ||
| Q2 25 | — | $391.3M | ||
| Q1 25 | — | $390.7M | ||
| Q4 24 | — | $390.1M | ||
| Q3 24 | — | $389.5M | ||
| Q2 24 | — | $388.9M | ||
| Q1 24 | — | $388.4M |
| Q4 25 | $343.6M | $274.2M | ||
| Q3 25 | $358.4M | $230.4M | ||
| Q2 25 | $308.9M | $204.3M | ||
| Q1 25 | $490.2M | $193.6M | ||
| Q4 24 | $466.8M | $194.0M | ||
| Q3 24 | $475.8M | $178.8M | ||
| Q2 24 | $448.5M | $132.5M | ||
| Q1 24 | $552.6M | $130.7M |
| Q4 25 | $580.8M | $949.9M | ||
| Q3 25 | $564.3M | $868.8M | ||
| Q2 25 | $721.5M | $815.3M | ||
| Q1 25 | $681.7M | $789.8M | ||
| Q4 24 | $693.0M | $785.0M | ||
| Q3 24 | $663.8M | $786.6M | ||
| Q2 24 | $742.1M | $749.5M | ||
| Q1 24 | $723.7M | $721.8M |
| Q4 25 | — | 1.43× | ||
| Q3 25 | — | 1.70× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.02× | ||
| Q4 24 | — | 2.01× | ||
| Q3 24 | — | 2.18× | ||
| Q2 24 | — | 2.93× | ||
| Q1 24 | — | 2.97× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $82.4M | $16.3M |
| Free Cash FlowOCF − Capex | — | $16.0M |
| FCF MarginFCF / Revenue | — | 8.6% |
| Capex IntensityCapex / Revenue | — | 0.2% |
| Cash ConversionOCF / Net Profit | 10.58× | 9.62× |
| TTM Free Cash FlowTrailing 4 quarters | — | $29.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $82.4M | $16.3M | ||
| Q3 25 | $20.5M | $35.7M | ||
| Q2 25 | $36.2M | $-26.5M | ||
| Q1 25 | $61.2M | $7.8M | ||
| Q4 24 | $103.1M | $-3.9M | ||
| Q3 24 | $70.2M | $-23.0M | ||
| Q2 24 | $35.0M | $22.7M | ||
| Q1 24 | $56.7M | $-29.7M |
| Q4 25 | — | $16.0M | ||
| Q3 25 | — | $35.3M | ||
| Q2 25 | — | $-28.9M | ||
| Q1 25 | — | $7.5M | ||
| Q4 24 | — | $-4.2M | ||
| Q3 24 | — | $-23.3M | ||
| Q2 24 | — | $21.6M | ||
| Q1 24 | — | $-31.5M |
| Q4 25 | — | 8.6% | ||
| Q3 25 | — | 20.9% | ||
| Q2 25 | — | -18.7% | ||
| Q1 25 | — | 6.0% | ||
| Q4 24 | — | -2.8% | ||
| Q3 24 | — | -16.5% | ||
| Q2 24 | — | 17.0% | ||
| Q1 24 | — | -28.5% |
| Q4 25 | — | 0.2% | ||
| Q3 25 | — | 0.2% | ||
| Q2 25 | — | 1.6% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 0.9% | ||
| Q1 24 | — | 1.6% |
| Q4 25 | 10.58× | 9.62× | ||
| Q3 25 | 1.00× | 2.06× | ||
| Q2 25 | 1.48× | — | ||
| Q1 25 | 2.56× | — | ||
| Q4 24 | 8.64× | -0.27× | ||
| Q3 24 | 6.11× | — | ||
| Q2 24 | 1.77× | — | ||
| Q1 24 | 2.89× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CRCT
| Platform | $83.9M | 41% |
| Connected Machines | $65.2M | 32% |
| Accessories And Materials | $54.4M | 27% |
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
